Donor-specific antibodies are associated with antibody-mediated rejection, acute cellular rejection, bronchiolitis obliterans syndrome, and cystic fibrosis after lung transplantation.

PubWeight™: 0.95‹?› | Rank: Top 15%

🔗 View Article (PMID 23260706)

Published in J Heart Lung Transplant on January 01, 2013

Authors

Leonard J Lobo1, Robert M Aris, John Schmitz, Isabel P Neuringer

Author Affiliations

1: University of North Carolina, Division of Pulmonary and Critical Care Medicine, 130 Mason Farm Rd, Campus Box 7020, Chapel Hill, NC 27599, USA. leonardlobo@gmail.com

Articles citing this

Antibody-mediated graft injury: complement-dependent and complement-independent mechanisms. Curr Opin Organ Transplant (2014) 0.91

Graft microvascular disease in solid organ transplantation. J Mol Med (Berl) (2014) 0.88

What's new in clinical solid organ transplantation by 2013. World J Transplant (2014) 0.81

MHC class I signaling: new functional perspectives for an old molecule. Tissue Antigens (2014) 0.80

The Influence of Immunosuppressive Agents on the Risk of De Novo Donor-Specific HLA Antibody Production in Solid Organ Transplant Recipients. Transplantation (2016) 0.79

Lung transplantation: chronic allograft dysfunction and establishing immune tolerance. Hum Immunol (2014) 0.79

Current State of Pediatric Lung Transplantation. Lung (2015) 0.77

IgM-Enriched Human Intravenous Immunoglobulin-Based Treatment of Patients With Early Donor Specific Anti-HLA Antibodies After Lung Transplantation. Transplantation (2016) 0.76

Antibody-mediated Rejection in Lung Transplantation. Curr Transplant Rep (2015) 0.75

Antibodies to HLA Molecules Mimic Agonistic Stimulation to Trigger Vascular Cell Changes and Induce Allograft Injury. Curr Transplant Rep (2015) 0.75

A severe Mycoplasma pneumoniae pneumonia inducing an acute antibody-mediated pulmonary graft rejection. Lung India (2017) 0.75

Autologous and Allogenous Antibodies in Lung and Islet Cell Transplantation. Front Immunol (2016) 0.75

Unraveling the Role of Allo-Antibodies and Transplant Injury. Front Immunol (2016) 0.75

Not All Antibodies Are Created Equal: Factors That Influence Antibody Mediated Rejection. J Immunol Res (2017) 0.75

Update on Chronic Lung Allograft Dysfunction. Curr Transplant Rep (2016) 0.75

Impact of ABO Incompatibility on the Development of Acute Antibody-Mediated Rejection in Kidney Transplant Recipients Presensitized to HLA. PLoS One (2015) 0.75

Pre-transplant Panel Reactive Antibody and Survival in Adult Cystic Fibrosis Patients After Lung Transplantation. Lung (2016) 0.75

Influence of HLA Mismatching on Survival in Lung Transplantation. Lung (2015) 0.75

Articles by these authors

Determination of ephedra alkaloids by liquid chromatography/tandem mass spectrometry. J AOAC Int (2003) 1.38

Metabolic and immune activation effects of treatment interruption in chronic HIV-1 infection: implications for cardiovascular risk. PLoS One (2008) 1.20

European cystic fibrosis bone mineralisation guidelines. J Cyst Fibros (2011) 1.12

A North American multilaboratory study of CD4 counts using flow cytometric panLeukogating (PLG): a NIAID-DAIDS Immunology Quality Assessment Program Study. Cytometry B Clin Cytom (2008) 1.06

Six-year molecular analysis of Burkholderia cepacia complex isolates among cystic fibrosis patients at a referral center for lung transplantation. J Clin Microbiol (2002) 1.06

C-C chemokine receptor 5 on stromal cells promotes pulmonary metastasis. Cancer Res (2005) 1.05

Epithelial kinetics in mouse heterotopic tracheal allografts. Am J Transplant (2002) 1.04

Vitamin d deficiency in cystic fibrosis. Int J Endocrinol (2010) 1.02

Burkholderia gladioli: five year experience in a cystic fibrosis and lung transplantation center. J Cyst Fibros (2006) 1.01

Liver allograft antibody-mediated rejection with demonstration of sinusoidal C4d staining and circulating donor-specific antibodies. Liver Transpl (2011) 0.98

Management of osteoporosis in adults with cystic fibrosis. Drugs (2004) 0.96

Growth factor upregulation during obliterative bronchiolitis in the mouse model. Am J Respir Crit Care Med (2002) 0.96

Efficacy of alendronate in adults with cystic fibrosis with low bone density. Am J Respir Crit Care Med (2003) 0.93

Sinusoidal C4d deposits in liver allografts indicate an antibody-mediated response: diagnostic considerations in the evaluation of liver allografts. Liver Transpl (2012) 0.92

Hierarchical contributions of allorecognition pathways in chronic lung rejection. Am J Respir Crit Care Med (2002) 0.91

Human leukocyte antigen mismatches predispose to the severity of bronchiolitis obliterans syndrome after lung transplantation. Chest (2003) 0.89

Post-transplantation lymphoproliferative disease: Epstein-Barr virus DNA levels, HLA-A3, and survival. Am J Respir Crit Care Med (2008) 0.89

Pulmonary immune responses to Propionibacterium acnes in C57BL/6 and BALB/c mice. Am J Respir Cell Mol Biol (2006) 0.88

Thermodilution and Fick cardiac outputs differ: impact on pulmonary hypertension evaluation. Can Respir J (2012) 0.86

MyD88 provides a protective role in long-term radiation-induced lung injury. Int J Radiat Biol (2012) 0.85

Update on cystic fibrosis-related bone disease: a special focus on children. Paediatr Respir Rev (2009) 0.82

Calcineurin inhibitor effects on growth and phenotype of human airway epithelial cells in vitro. Am J Transplant (2005) 0.82

Safety, tolerability, and pharmacokinetic effects of thalidomide in patients infected with human immunodeficiency virus: AIDS Clinical Trials Group 267. J Infect Dis (2002) 0.81

Epidural pneumatosis and diffuse soft tissue free air as a complication of diabetic ketoacidosis. Am J Respir Crit Care Med (2012) 0.79

'Old' bones in young bodies: the tale of cystic fibrosis. Curr Opin Endocrinol Diabetes Obes (2009) 0.79

Increased plasma mannose binding lectin levels are associated with bronchiolitis obliterans after lung transplantation. Respir Res (2012) 0.78

Carboxylated osteocalcin levels in cystic fibrosis. Am J Respir Crit Care Med (2003) 0.77

Pan-Resistant Achromobacter xylosoxidans and Stenotrophomonas maltophilia Infection in Cystic Fibrosis Does Not Reduce Survival After Lung Transplantation. Transplantation (2015) 0.77

High incidence of gastric bezoars in cystic fibrosis patients after lung transplantation. Transplantation (2006) 0.77

Managing complications following lung transplantation. Expert Rev Respir Med (2009) 0.77

Safety and feasibility of obtaining wedged pulmonary artery samples and differential distribution of biomarkers in pulmonary hypertension. Pulm Circ (2012) 0.75

Screening for portopulmonary hypertension with transthoracic echocardiography: implications for early mortality associated with liver transplantation. Am J Respir Crit Care Med (2009) 0.75

Does ischemia-reperfusion injury after solid organ transplantation damage native organs? Transplantation (2014) 0.75

Affordable, abbreviated roche monitor assay for quantification of human immunodeficiency virus type 1 RNA in plasma. J Clin Microbiol (2005) 0.75

Is it time to prospectively match human leukocyte antigen proteins for lung transplantation? Transplantation (2010) 0.75

PX3.102, a novel chinese herb extract, diminishes chronic airway allograft rejection. Transplantation (2004) 0.75

Determination of low-level agricultural residues in soft drinks and sports drinks by liquid chromatography/tandem mass spectrometry: single-laboratory validation. J AOAC Int (2007) 0.75

Determination of low-level agricultural residues in soft drinks and sports drinks by gas chromatography with mass-selective detection: single-laboratory validation. J AOAC Int (2007) 0.75